beezam.com

What It Is

Beezam positions itself as a “GLP-1 Success” food operating system for people using GLP-1-related medications such as Wegovy, Mounjaro, Saxenda, and Trulicity. It is not a traditional calorie tracker. Instead, it tries to predict which ingredients or meals may trigger side effects such as nausea, vomiting, and delayed gastric emptying based on an individual’s medication schedule, food intake, and symptom feedback.

Core Capabilities

The page highlights its patent-pending N-of-1 causal inference capabilities. It continuously updates each ingredient’s personal risk profile through Bayesian Posterior Updating; uses an 8-layer Biological Veto Gate to intercept high-risk meals before eating; combines L1 Sparsity Cutoffs and 90/10 Masking to identify true triggers; and adds a pharmacokinetic model to estimate drug concentration based on the dosing plan, helping determine high-risk days. Volumetric fraction analysis is another notable feature, distinguishing dose differences such as “a small amount of minced garlic” versus “a whole clove of garlic.”

Pricing and Availability

The page clearly states: “Free to download. No subscription required for core features.” This indicates that the core features are free to download and do not require a subscription. However, it does not disclose whether there are premium features, enterprise pricing, payment methods, supported platforms, or app store links. For B2B use, the page says organizations can get in touch for partnerships, targeting pharmaceutical companies and digital health clinics with improved patient adherence and real-world evidence data.

Pros and Cons

Its strength lies in a highly focused use case: addressing the problem of GLP-1 users stopping medication due to gastrointestinal side effects. Compared with general-purpose diet apps, it takes drug concentration, individual response, and ingredient volume into account, which in theory makes it closer to real-world usage. The limitations are also clear: the team remains anonymous, and its clinical validation mainly comes from simulations and user logs. Although the page cites metrics such as N=100, NPV, and 96% Bio-Specificity, it lacks public papers, review procedures, and detailed real clinical trial information. On privacy, it only mentions on-device intelligence, without explaining medical data compliance, storage, or sharing mechanisms.

Who It’s For and Access from China

Beezam is suitable for people currently using GLP-1 medications who frequently experience nausea or food aversion and need a more precise trial-and-error approach to diet. It may also suit digital health organizations and pharmaceutical companies focused on patient retention. Access from China, a Chinese-language interface, domestic payment options, and local compliance information are all undisclosed, so actual availability is unknown. If you only need basic diet tracking, alternatives include MyFitnessPal, Cronometer, and 薄荷健康; however, these tools generally do not offer GLP-1 pharmacokinetic modeling or personalized trigger identification.